Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome

Abstract

beta-blockers are associated with a significant reduction in cardiac events in LQTS patients. However, syncope, aborted cardiac arrest, and LQTS-related death continue to occur while patients are on prescribed beta-blockers, particularly in those who were symptomatic before starting this therapy.